Skip to main content
. 2021 Feb 5;10:522332. doi: 10.3389/fonc.2020.522332

Table 1.

Clinical association between ENDOU expression and clinicopathological variables in HNSCC patients.

Characteristics n No. of Patients (%) ENDOU
Low High p
Status 500 0.03
Alive 282(56.4) 129 163
Death 218(43.6) 121 97
Gender 500 0.011
Female 133(26.6) 54 79
Male 367(73.4) 196 171
Age 499 0.616
<60 220(44.1) 107 113
≥60 279(55.9) 142 137
Alcohol_history 489 0.017
No 157(32.1) 66 91
Yes 332(67.9) 178 154
Clinical_N 478 0.001
N0 239(50) 101 138
N1-3 239(50) 139 100
Clinical_T 485 0.731
T1-2 176(36.3) 86 90
T3-4 309(63.7) 156 153
Clinical_stage 486 0.096
I-II 114(23.5) 49 65
III-IV 372(76.5) 193 179
Lymph_node_count 407 0.52
Low 203(49.9) 102 101
High 204(50.1) 96 108
Lymphovascular_invasion_present 339 0.001
No 219(64.6) 95 124
Yes 120(35.4) 74 46
Neoplasm_histologic_grade 481 0
G1-2 360(74.8) 151 209
G3-4 121(25.2) 88 33
Recurrence 442 0.39
No 317(71.7) 153 164
Yes 125(28.3) 66 59
Pathologic_N 407 0
N0 171(42.0) 63 108
N1-3 236(58.0) 132 104
Pathologic_T 444 0.799
T1-2 177(39.9) 84 93
T3-4 267(60.1) 130 137
Pathologic_stage 435 0.133
I-II 98(22.5) 41 57
III-IV 337(77.5) 170 167
Perineural_invasion 351 0.311
No 186(53.0) 88 98
Yes 165(47.0) 87 78
Smoker 490 0.914
No 111(22.7) 56 55
Yes 379(77.3) 189 190